TIES | $1,500,000 | (Apr 30, 2026)
Certifyde | $2,000,000 | (Apr 30, 2026)
Parallel Web Systems | $100,000,000 | (Apr 30, 2026)
Certified by Founder
Lodge
Fore Biotherapeutics
start up
United States
- Philadelphia, PA
- 25/08/2023
- Series D
- $75,000,000
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics. Deeply rooted in science and innovation, our vision is to compassionately contribute to solving cancer.
- Industry Biotechnology
- Website https://fore.bio/
- LinkedIn https://www.linkedin.com/company/forebiotherapeutics/about/
Skyfire | AI | $11,000,000 | (Apr 30, 2026)
General Analysis | $10,000,000 | (Apr 30, 2026)
Fence | $20,000,000 | (Apr 30, 2026)
Tacalyx GmbH | $12,843,270 | (Apr 30, 2026)
OpenObserve | $10,000,000 | (Apr 30, 2026)
Crazy Mountain | $15,000,000 | (Apr 30, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)